Pharmacologic Chronic Pain Treatment

Published Online: Thursday, October 20, 2011
Follow Pharmacy_Times:
In this video, Mary Lynn McPherson, PharmD, BCPS, CPE, talks about the basic tenets of pharmacologic chronic pain treatment. Dr. McPherson, who is professor and vice chair of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and president of the American Society of Pain Educators, highlights the importance of conducting a comprehensive assessment of patient's pain compliant and talks about the use of rational polypharmacy.

Related Articles
While extended-release opioid analgesics are an essential component of pain management, abuse and misuse of these medications can cause substantial morbidity and mortality.
Not every patient requires an aspirin a day.
The rate of deaths from opiate medications in the United States has increased 4-fold over the past decade.
Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$